Effects of Botulinum Toxin Injection on Reducing Myogenic Artifacts during Video-EEG Monitoring: A Longitudinal Study

References

• Alqadi K, Sankaraneni R, Thome U, Kotagal P. 2016. Semiology of hypermotor (hyperkinetic) seizures. Epilepsy Behav. 54:137–141. doi:10.1016/j.yebeh.2015.11.017. eng.
   PubMed Web of Science ®Google Scholar
• Baumgartner C, Koren JP, Britto-Arias M, Zoche L, Pirker S 2019. Presurgical epilepsy evaluation and epilepsy surgery. F1000Res. 8. eng.
   Google Scholar
• Bjornson K, Hays R, Graubert C, Price R, Won F, McLaughlin JF, Cohen M. 2007. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation. Pediatrics. 120(1):49–58. doi:10.1542/peds.2007-0016. eng.
   PubMed Web of Science ®Google Scholar
• Boytsova JA, Danko SG, Medvedev SV. 2016. When EMG contamination does not necessarily hide high-frequency EEG: scalp electrical recordings before and after Dysport injections. Exp Brain Res. 234(11):3091–3106. doi:10.1007/s00221-016-4708-3. eng.
   PubMed Web of Science ®Google Scholar
• Brin MF, Boodhoo TI, Pogoda JM, James LM, Demos G, Terashima Y, Gu J, Eadie N, Bowen BL. 2009. Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: a meta-analysis of individual patient data from global clinical registration studies in 1678 participants. J Am Acad Dermatol. 61(6):961–970.e961-911. doi:10.1016/j.jaad.2009.06.040. eng.
   PubMed Web of Science ®Google Scholar
• Burgess RC. 2019. Magnetoencephalography for localizing and characterizing the epileptic focus. Handb Clin Neurol. 160:203–214.
   PubMedGoogle Scholar
• Cascino GD, Brinkmann BH. 2021. Advances in the surgical management of epilepsy: drug-resistant focal epilepsy in the adult patient. Neurol Clin. 39(1):181–196.
   PubMed Web of Science ®Google Scholar
• Costantin L, Bozzi Y, Richichi C, Viegi A, Antonucci F, Funicello M, Gobbi M, Mennini T, Rossetto O, Montecucco C. 2005. Antiepileptic effects of botulinum neurotoxin E. J Neurosci. 25(8):1943–1951.
   PubMed Web of Science ®Google Scholar
• Delcamp C, Cormier C, Chalard A, Amarantini D, Gasq D. 2022. Botulinum toxin combined with rehabilitation decrease corticomuscular coherence in stroke patients. Clin Neurophysiol. 136:49–57.
   PubMed Web of Science ®Google Scholar
• Eisenschenk S, Gilmore RL, Uthman B, Valenstein E, Gonzalez R. 2002. Botulinum toxin-induced paralysis of frontotemporal muscles improves seizure focus localization. Neurology. 58(2):246–249. doi:10.1212/WNL.58.2.246. eng.
   PubMed Web of Science ®Google Scholar
• Ekstein D, Shih LC, Sheen V. 2010. Neurological picture. Focal botulinum toxin injections lead to rapid resolution of myogenic artefact during EEG monitoring. J Neurol Neurosurg Psychiatry. 81(6):637–638. doi:10.1136/jnnp.2009.181446. eng.
   PubMed Web of Science ®Google Scholar
• Flynn TC. 2006. Update on botulinum toxin. Semin Cutan Med Surg. 25(3):115–121. doi:10.1016/j.sder.2006.06.003. eng.
   PubMed Web of Science ®Google Scholar
• Grant AC, Hermanowicz N. 2007. Reduction of EEG myogenic artifact with botulinum toxin during video-EEG monitoring. Epilepsia. 48(2):324–329. doi:10.1111/j.1528-1167.2006.00930.x. eng.
   PubMed Web of Science ®Google Scholar
• Herwig U, Satrapi P, Schönfeldt-Lecuona C. 2003. Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr. 16(2):95–99.
   PubMed Web of Science ®Google Scholar
• Jabeen A, Kandadai RM, Kannikannan MA, Borgohain R. 2011. Guidelines for the use of botulinum toxin in movement disorders and spasticity. Ann Indian Acad Neurol. 14(Suppl 1):S31–34. doi:10.4103/0972-2327.83099. eng.
   PubMedGoogle Scholar
• Kang JS, Krakow K, Roggendorf J, Steinmetz H, Hilker R. 2009. Botulinum toxin treatment of epilepsia partialis continua. Mov Disorders. 24(1):141–143.
   PubMed Web of Science ®Google Scholar
• Kaya I. 2019. A brief summary of EEG artifact handling in Brain-Computer Interface. London: IntechOpen. doi: 10.5772/intechopen.94618.
   Google Scholar
• Kępczyńska K, Domitrz I. 2022. Botulinum toxin-A current place in the treatment of chronic migraine and other primary headaches. Toxins (Basel). 14(9):619. doi: 10.3390/toxins14090619. eng.
   PubMed Web of Science ®Google Scholar
• Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Hauser WA, Mathern G, Moshé SL, Perucca E, Wiebe S, French J. 2010. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 51(6):1069–1077. doi: 10.1111/j.1528-1167.2009.02397.x.
   Google Scholar
• Markey AC. 2004. Dysport. Dermatol Clin. 22(2):213–219.
   PubMed Web of Science ®Google Scholar
• Matthies HK, Brödemann R. 1981. Application of Fast Fourier Transform in electroencephalography. Biomet J. 23(8):789–794.
   Google Scholar
• Medscape. 2022. abobotulinumtoxinA (Rx). New York: Medscape; [ accessed April 17, 2022]. https://reference.medscape.com/drug/dysport-abobotulinumtoxina-999220.
   Google Scholar
• Multani I, Manji J, Hastings-Ison T, Khot A, Graham K. 2019. Botulinum toxin in the management of children with cerebral palsy. Paediatr Drugs. 21(4):261–281. doi:10.1007/s40272-019-00344-8. eng.
   PubMed Web of Science ®Google Scholar
• Ney JP, Joseph KR. 2007. Neurologic uses of botulinum neurotoxin type A. Neuropsychiatr Dis Treat. 3(6):785–798. doi:10.2147/NDT.S1612. eng.
   PubMedGoogle Scholar
• Nigam PK, Nigam A. 2010. Botulinum toxin. Indian J Dermatol. 55(1):8–14. doi:10.4103/0019-5154.60343. eng.
   PubMedGoogle Scholar
• Nitta N, Usui N, Kondo A, Tottori T, Terada K, Araki Y, Nakaoka K, Kawaguchi N, Idebuchi G, Nozaki K. 2019. Semiology of hyperkinetic seizures of frontal versus temporal lobe origin. Epileptic Disord. 21(2):154–165.
   PubMed Web of Science ®Google Scholar
• Papavasiliou AS, Nikaina I, Foska K, Bouros P, Mitsou G, Filiopoulos C. 2013. Safety of botulinum toxin A in children and adolescents with cerebral palsy in a pragmatic setting. Toxins. 5(3):524–536.
   PubMed Web of Science ®Google Scholar
• Placantonakis DG, Schwartz TH. 2009. Localization in epilepsy. Neurol Clin. 27(4):1015–1030. doi:10.1016/j.ncl.2009.08.004. eng.
   PubMed Web of Science ®Google Scholar
• Rao KR, Kim DN, Hwang -J-J. 2010. Fast Fourier Transform - algorithms and applications. New York: Springer Publishing Company, Incorporated.
   Google Scholar
• Selim R Benbadis DAR. 2019. EEG artifacts. Medscape Journal of Medicine [accessed 2021]. https://emedicine.medscape.com/article/1140247-overview#a2.
   Google Scholar
• Small R. 2014. Botulinum toxin injection for facial wrinkles. Am Fam Physician. 90(3):168–175. eng.
   PubMed Web of Science ®Google Scholar
• Sundaram H, Signorini M, Liew S, Trindade de Almeida AR, Wu Y, Vieira Braz A, Fagien S, Goodman GJ, Monheit G, Raspaldo H, et al. 2016. Global aesthetics consensus: botulinum toxin type A–evidence-based review, emerging concepts, and consensus recommendations for aesthetic use, including updates on complications. Plast Reconstr Surg. 137(3):518e–529e. eng.
   PubMed Web of Science ®Google Scholar
• Tufenkjian K, Lüders HO. 2012. Seizure semiology: its value and limitations in localizing the epileptogenic zone. J Clin Neurol. 8(4):243–250. doi:10.3988/jcn.2012.8.4.243. eng.
   PubMed Web of Science ®Google Scholar
• van Boxtel A. 2001. Optimal signal bandwidth for the recording of surface EMG activity of facial, jaw, oral, and neck muscles. Psychophysiology. 38(1):22–34. doi:10.1111/1469-8986.3810022. eng.
   PubMed Web of Science ®Google Scholar
• van Boxtel A, Goudswaard P, Schomaker LRB. 1984. Amplitude and bandwidth of the frontalis surface EMG: effects of electrode parameters. Psychophysiology. 21(6):699–707.
   PubMed Web of Science ®Google Scholar
• von Oertzen TJ. 2018. PET and ictal SPECT can be helpful for localizing epileptic foci. Curr Opin Neurol. 31(2):184.
   PubMed Web of Science ®Google Scholar
• World Medical Association. 2013. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 310(20):2191–2194.
   PubMed Web of Science ®Google Scholar
• Zack MM, Kobau R. 2017. National and state estimates of the numbers of adults and children with active epilepsy—United States, 2015. MMWR Morb Mortal Wkly Rep. 66(31):821.
   PubMed Web of Science ®Google Scholar
• Ziessman HA, O’Malley JP, Thrall JH, Fahey FH. 2014. Preface. In: Ziessman HA, O’Malley JP, Thrall JH, editors. Nuclear medicine. Fourth ed. Philadelphia, PA: W.B. Saunders; p. ix.
   Google Scholar